Zurcher Kantonalbank Zurich Cantonalbank Trims Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Zurcher Kantonalbank Zurich Cantonalbank reduced its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 18.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 60,394 shares of the company’s stock after selling 13,591 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Henry Schein were worth $4,179,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in HSIC. FMR LLC lifted its holdings in Henry Schein by 7.8% during the 3rd quarter. FMR LLC now owns 3,280,890 shares of the company’s stock valued at $239,177,000 after buying an additional 237,888 shares in the last quarter. Southpoint Capital Advisors LP raised its stake in shares of Henry Schein by 30.0% during the third quarter. Southpoint Capital Advisors LP now owns 2,600,000 shares of the company’s stock valued at $189,540,000 after acquiring an additional 600,000 shares in the last quarter. Nuance Investments LLC boosted its holdings in shares of Henry Schein by 22.3% in the third quarter. Nuance Investments LLC now owns 2,278,081 shares of the company’s stock valued at $166,072,000 after purchasing an additional 414,748 shares during the period. Clarkston Capital Partners LLC grew its stake in Henry Schein by 5.4% in the third quarter. Clarkston Capital Partners LLC now owns 1,397,805 shares of the company’s stock worth $101,900,000 after purchasing an additional 71,560 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. increased its holdings in Henry Schein by 1.4% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,191,677 shares of the company’s stock worth $82,464,000 after purchasing an additional 16,616 shares during the period. 96.62% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

HSIC has been the subject of several research reports. UBS Group lowered their target price on Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a report on Wednesday, February 26th. Barrington Research reiterated an “outperform” rating and set a $90.00 target price on shares of Henry Schein in a report on Wednesday, February 26th. Mizuho assumed coverage on shares of Henry Schein in a research report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 target price on the stock. Bank of America raised shares of Henry Schein from an “underperform” rating to a “buy” rating and upped their price target for the stock from $69.00 to $84.00 in a research report on Monday, January 6th. Finally, Wells Fargo & Company began coverage on shares of Henry Schein in a report on Friday, February 14th. They set an “equal weight” rating and a $80.00 price objective on the stock. Six investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $81.10.

Henry Schein Stock Performance

Shares of HSIC opened at $70.58 on Friday. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The firm has a market cap of $8.76 billion, a PE ratio of 29.05, a P/E/G ratio of 2.13 and a beta of 0.90. Henry Schein, Inc. has a 12 month low of $63.67 and a 12 month high of $82.49. The stock has a fifty day moving average price of $74.81 and a 200-day moving average price of $72.60.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business had revenue of $3.19 billion during the quarter, compared to analysts’ expectations of $3.25 billion. During the same quarter last year, the business posted $0.66 earnings per share. The company’s quarterly revenue was up 5.8% compared to the same quarter last year. Equities research analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.